Protective effect of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) polymerase in distant liver injury induced by renal ischemia-reperfusion in rats

European Review for Medical and Pharmacological Sciences

Volumn 18, Issue 1, 2014, Pages 34-38

  Tas Hekimoglu, A ^a   Toprak, G ^a   Akkoc, H ^a   Evliyaoglu, O ^a   Tas, T ^b   Kelle, I ^a   Colpan, L ^a  

^a DICLE UNIVERSITY   (Turkey)

^b Department of Clinical Biochemistry Faculty of Medicine Dicle University ^*  (Turkey)

Author keywords

3 aminobenzamide; Ischemia reperfusion; Ox idative stress; Poly (ADP Ribose) polymerase (PARP); Remote liver injury

Indexed keywords

3 AMINOBENZAMIDE; ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE; MALONALDEHYDE; NITRIC OXIDE; 3-AMINOBENZAMIDE; BENZAMIDE DERIVATIVE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PON 1 PROTEIN, RAT; PROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; ENZYME ACTIVITY; ENZYME INHIBITION; KIDNEY ISCHEMIA; LIVER INJURY; LIVER PROTECTION; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; REPERFUSION INJURY; SHAM PROCEDURE; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; COMPLICATION; DRUG EFFECTS; KIDNEY DISEASES; LIVER; LIVER DISEASES; METABOLISM; WISTAR RAT;

ANIMALS; ARYLDIALKYLPHOSPHATASE; BENZAMIDES; KIDNEY DISEASES; LIVER; LIVER DISEASES; MALE; MALONDIALDEHYDE; NITRIC OXIDE; OXIDATIVE STRESS; POLY(ADP-RIBOSE) POLYMERASES; PROTECTIVE AGENTS; RATS, WISTAR; REPERFUSION INJURY;

EID: 84896940503     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. BELLOMO R, KELLUM JA, RONCO C. Acute kidney injury. Lancet 2012; 380(9843): 756-766.
2. LIANGOS O, WALD R, O'BELL JW, PRICE L, PEREIRA B.J., JABER BL. Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey. Clin J Am Soc Nephrol 2006; 1: 43-51.
3. SERTESER M, KOKEN T, KAHRAMAN A., YILMAZ K, AKBULUT G, DILEK ON Changes in hepatic TNF-alpha levels, antioxidant status, and oxidation products after renal ischemia/reperfusion injury in mice. J Surg Res 2002; 107: 234-240.
4. PARK SW, CHEN SW, KIM M, BROWN K.M., KOLLS JK, D'A-GATI VD, LEE HT. Cytokines induce small intestine and liver injury after renal ischemia or nephrecto-my. Lab Invest 2011; 91: 63-84.
5. WANG B, BAI M, BAI Y., LI Q. Liver injury following renal ischemia reperfusion in rats. Transplant Proc 2010; 42: 3422-3426.
6. KADKHODAEE M, GOLAB F, ZAHMATKESH M., GHAZNAVI R, HEDAYATI M, ARAB H.A., OSTAD SN, SOLEIMANI M. Effects of different periods of renal ischemia on liver as a remote organ. World J Gastroenterol 2009; 15: 1113-1118.
7. KAÇMAZ A., USER EY, SEHIRLI A.O., TILKI M., OZKAN S, SENER G. Protective effect of melatonin against is-chemia/reperfusion-induced oxidative remote organ injury in the rat. Surg Today 2005; 35: 744-750.
8. GERO D, SZABÓ C. Role of the peroxynitrite-poly (ADP-ribose) polymerase pathway in the patho-genesis of liver injury. Curr Pharm Des 2006; 12: 2903-2910.
9. SZABO C, DAWSON VL Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reper-fusion. Trends Pharmacol Sci 1998; 19: 287-298.
10. SHALL S, MURCIA G. Poly(ADP-ribose) polymerase-1: What have we learned from the deficient mouse model? Mutat Res 2000; 460: 1-15.
11. TENTORI L, PORTARENA I, GRAZIANI G. Potential clinical applications of poly(ADP-ribose) polymerase (PARP) inhibitors. Pharmacol Res 2002; 45: 73-85.
12. THIEMERMANN C, BOWES J, MYINT F P, VANE JR Inhibition of the activity of poly(ADP ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle. Proc Natl Acad Sci U S A 1997; 94: 679-683.
13. HEKIMOGLU A, KURCER Z, ARAL F., BABA F, ATESSAHIN A, SAKIN F. Effects of 3-aminobenzamide on unilateral testicular ischemia-reperfusion injury: what is the role of PARP inhibition? Can J Physiol Pharmacol 2010; 88: 1123-1129.
14. BOWES J, THIEMERMANN C. Effects of inhibitors of the activity of poly (ADP-ribose) synthetase on the liver injury caused by ischaemia-reperfusion: a comparison with radical scavengers. Br J Pharmacol 1998; 124: 1254-1260.
15. OZTAS E, GUVEN A, TURK E., UYSAL B, AKGUL EO, CAYCI T, ERSOZ N., KORKMAZ A. 3-aminobenzamide, apoly ADP ribose polymerase inhibitor, attenuates renal is-chemia/reperfusion injury. Ren Fail 2009; 31: 393-399.
16. LOWRY OH, ROSEBROUGH NJ, FARR A.L., RANDALL RJ Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
17. OHKAWA H, OHISHI N, YAGI K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-358.
18. CORTAS NK, WAKID NW Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 1990; 36: 1440-1443.
19. ECKERSON HW, WYTE CM, LA DU BN. The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet 1983; 35: 1126-1138.
20. EREL O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004; 37: 112-119.
21. EREL O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005; 38: 1103-1111.
22. OZTURK E, BALAT O, ACILMIS Y.G., OZCAN C., PENCE S, EREL Ö. Measurement of the placental total antiox-idant status in preeclamptic women using a novel automated method. J Obstet Gynaecol Res 2011; 37: 337-342.
23. AYCICEK A, EREL O, KOCYIGIT A. Increased oxidative stress in infants exposed to passive smoking. Eur J Pediatr 2005; 164: 775-778.
24. ZINGARELLI B, CUZZOCREA S, ZSENGELLÉR Z, SALZMAN A.L., SZABÓ C. Protection against myocardial ischemia and reperfusion injury by 3-aminobenza-mide, an inhibitor of poly(-ADP-ribose) syn-thetase. Cardiovasc Res 1997; 36: 205-215.
25. ZINGARELLI B, O'CONNOR M, WONG H, SALZMAN A.L., SZABÓ C. Peroxynitrite-mediated DNA strand breakage activates poly-adenosine diphosphate ribosyl syn-thetase and causes cellular energy depletion in macrophages stimulated with bacterial lipopolysac-charide. J Immunol 1996; 156: 350-358.
26. WINTERSBERGER U, WINTERSBERGER E. POLY ADP-ribo-sylation-a cellular emergency reaction? FEBS Lett 1985; 188: 189-191.
27. COCHRANE G. Mechanisms of oxidant injury of cells. Mol Aspects Med 1991 12: 137-147.
28. BANASIK M, KOMURA H, SHIMOYAMA M., UEDA K. Specific inhibitors of poly(ADP-ribose) synthetase and mono (ADPribosyl) transferase. J Biol Chem 1992; 267: 1569-1575.
29. UEDA K, HAYAISHI O. ADP-ribosylation. Annu Rev Biochem 1985; 54: 73-100.
30. BERGER NA. Poly(ADP-ribose) in the cellular response to DNA damage. Radiat Res 1985; 101: 4-15.
31. PACHER P, LIAUDET L, MABLEY J.G., CZIRÁKI A, HASKÓ G, SZABÓ C. Beneficial effects of a novel ultrapotent poly (ADP-ribose) polymerase inhibitor in murine models of heart failure. Int J Mol Med 2006; 17: 369-375.
32. ESCHWEGE P, PARADIS V, CONTI M., HOLSTEGE A, RICHET F, DETEVE J., MENAGER P, LEGRAND A, JARDIN A, BEDOSSA P, BENOIT G. In situ detection of lipid peroxidation by-products as markers of renal ischemia injuries in rat kidneys. J Urol 1999; 162: 553-557.
33. VAGHASIYA JD, SHETH NR, BHALODIA Y.S., JIVANI N P. Exaggerated liver injury induced by renal ischemia reperfusion in diabetes: effect of exenatide. Saudi J Gastroenterol 2010; 16: 174-180.
34. IERI SO, GEDIK IE, ERZIK C, USLU B, ARBAK S, GEDIK N, YEEN BC. Oxytocin ameliorates skin damage and oxidant gastric injury in rats with thermal trauma. Burns 2008; 34: 361-369.
35. DAVIES GR, SIMMONDS NJ, STEVENS T.R., GRANDISON A., BLAKE DR, RAMPTON DS Mucosal reactive oxygen metabolite production in duodenal ulcer disease. Gut 1992; 33: 1467-1472.
36. EREL O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004; 37: 277-285.
37. CIKRIKCIOGLU MA, HURSITOGLU M, ERKAL H., KINAS BE, SZTAJZEL J, CAKIRCA M, ARSLAN A.G., EREK A., HALAC G, TUKEK T. Oxidative stress and autonomic nervous system functions in restless legs syndrome. Eur J Clin Invest 2011; 41: 734-742.
38. HARMA M, HARMA M, EREL O. Increased oxidative stress in patients with hydatidiform mole. Swiss Med Wkly 2003; 133: 563-566.
39. AVIRAM M, ROSENBLAT M. Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radic Biol Med 2004; 37: 1304-1316.
40. HASHEMI M, BAHARI A, HASHEMZEHI N., MOAZENI-ROODI A, SHAFIEIPOUR S, BAKHSHIPOUR A., GHAVAMI S. Serum paraoxonase and arylesterase activities in Iranian patients with nonalcoholic fatty liver disease. Pathophysiology 2012; 738: 1-5.
41. MARSILLACH J, BERTRAN N, CAMPS J., FERRE N, RIU F, TOUS M., COLL B, ALONSO-VILLAVERDE C, JOVEN J. The role of circulating monocyte chemoattractant pro-tein-1 as a marker of hepatic inflammation in patients with chronic liver disease. Clin Biochem 2005; 38: 1138-1140.
42. JAESCHKE H. Molecular mechanisms of hepatic is-chemiareperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 2003; 284: 15-26.
43. WANG Y, MATHEWS WR, GUIDO D.M., FARHOOD A., JAESCHKE H. Inhibition of nitric oxide synthesis aggravates reperfusion injury after hepatic ischemia and endotoxemia. Shock 1995; 4: 282-288.
44. HINES IN, KAWACHI S, HARADA H., PAVLICK K P, HOFFMAN JM, BHARWANI S, WOLF R.A., GRISHAM MB. Role of nitric oxide in liver ischemia and reperfusion injury. Mol Cell Biochem 2002; 1: 229-237.
45. KAWACHI S, HINES IN, LAROUX F.S., HOFFMAN J., BHAR-WANI S, GRAY L, LEFFER D., GRISHAM MB. Nitric oxide synthase and postischemic liver injury. Biochem Biophys Res Commun 2000; 276: 851-854.
46. KÖKEN T., INAL M. The effect of nitric oxide on is-chemia- reperfusion injury in rat liver. Clin Chim Acta 1999; 288: 55-62.
47. UHLMANN D, UHLMANN S, SPIEGEL HU Endothelin/ni-tric oxide balance influences hepatic ischemia-reperfusion injury. J Cardiovasc Pharmacol 2000; 36: 212-214.